About Algorithmic Biologics
Algorithmic Biologics is a company based in Bengaluru (India) founded in 2021 by Manoj Gopalkrishnan. Algorithmic Biologics has raised $2.84 million across 3 funding rounds from investors including Bharat Fund and Axilor Ventures. The company has 1 employees as of April 02, 2024. Algorithmic Biologics operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
- Headquarter Bengaluru, India
- Employees 1 as on 02 Apr, 2024
- Founders Manoj Gopalkrishnan
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Algorithmic Biologics Private Limited
- Date of Incorporation 03 Mar, 2021
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$46.14 K (USD)-1.31as on Mar 31, 2023
-
Net Profit
-$69.34 K (USD)-20.78as on Mar 31, 2023
-
EBITDA
-$111.97 K (USD)-86.75as on Mar 31, 2023
-
Total Equity Funding
$2.84 M (USD)
in 3 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Nov 23, 2023
-
Investors
Bharat Fund
& 1 more
-
Employee Count
1
as on Apr 02, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Algorithmic Biologics
Algorithmic Biologics has successfully raised a total of $2.84M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $2.5M
-
First Round
First Round
(13 Jul 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Seed - Algorithmic Biologics | Valuation | Bharat Innovation Fund | |
| Jan, 2022 | Amount | Seed - Algorithmic Biologics | Valuation |
investors |
|
| Jul, 2021 | Amount | Seed - Algorithmic Biologics | Valuation | Axilor Ventures |
|
Investors in Algorithmic Biologics
Algorithmic Biologics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bharat Fund and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding for IP-driven deep-tech and digitization-led inclusive solutions.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early-stage startups in technology sectors.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Algorithmic Biologics
Financial Statements - Algorithmic Biologics
Algorithmic Biologics Comparisons
Competitors of Algorithmic Biologics
Algorithmic Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| domain | founded_year | HQ Location |
Developer of drugs to treat various diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine language and computational platform for drug discovery
|
|
| domain | founded_year | HQ Location |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| domain | founded_year | HQ Location |
Digital technology for biomedicinal molecule development in research is utilized.
|
Frequently Asked Questions about Algorithmic Biologics
Algorithmic Biologics was founded in 2021.
Algorithmic Biologics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Manoj Gopalkrishnan is the current CEO of Algorithmic Biologics. They have also founded this company.
Algorithmic Biologics is a funded company, having raised a total of $2.84M across 3 funding rounds to date. The company's 1st funding round was a Seed of $341.98K, raised on Jul 13, 2021.
As of Apr 02, 2024, the latest employee count at Algorithmic Biologics is 1.
Annual revenue of Algorithmic Biologics is $46.14K as on Mar 31, 2023.
Provider of software solutions for molecular diagnostics and discovery. The company offers Tapestry that integrates with standard molecular testing workflows, enabling the execution of computing applications that enhance molecular testing.
Algorithmic Biologics has 2 investors. Key investors include Bharat Fund, and Axilor Ventures.
The valuation of Algorithmic Biologics is $10.93M as of Nov 2023.